The anti-Leishmania potential of bioactive compounds derived from naphthoquinones and their possible applications. A systematic review of animal studies

Leishmaniasis affects millions of people worldwide, and available treatments have severe limitations. Natural and derivative products are significant sources of innovative therapeutic agents. Naphthoquinones are natural or synthetic chemical compounds with broad biological activity. This systematic...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Parasitology research (1987) 2022-05, Vol.121 (5), p.1247-1280
Hauptverfasser: Ramos-Milaré, Áquila Carolina Fernandes Herculano, Oyama, Jully, Murase, Letícia Sayuri, Souza, João Vítor Perez, Guedes, Bárbara Silva, Lera-Nonose, Daniele Stéfanie Sara Lopes, Monich, Mariana Terron, Brustolin, Aline Ávila, Demarchi, Izabel Galhardo, Teixeira, Jorge Juarez Vieira, Lonardoni, Maria Valdrinez Campana
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1280
container_issue 5
container_start_page 1247
container_title Parasitology research (1987)
container_volume 121
creator Ramos-Milaré, Áquila Carolina Fernandes Herculano
Oyama, Jully
Murase, Letícia Sayuri
Souza, João Vítor Perez
Guedes, Bárbara Silva
Lera-Nonose, Daniele Stéfanie Sara Lopes
Monich, Mariana Terron
Brustolin, Aline Ávila
Demarchi, Izabel Galhardo
Teixeira, Jorge Juarez Vieira
Lonardoni, Maria Valdrinez Campana
description Leishmaniasis affects millions of people worldwide, and available treatments have severe limitations. Natural and derivative products are significant sources of innovative therapeutic agents. Naphthoquinones are natural or synthetic chemical compounds with broad biological activity. This systematic review aimed to evaluate the potential anti- Leishmania activity of bioactive compounds derived from naphthoquinones in animal models. Conducted in accordance with PRISMA guidelines, two blocks of MeSH terms were assembled: group I, Leishmania OR Leishmaniasis; group II, Atovaquone OR Lapachol OR Beta lapachone OR Naphthoquinones. The search was performed on PubMed, Web of Science, SCOPUS, EMBASE, and Lilacs databases. Twenty-four articles were retrieved and submitted for quality assessment using the SYRCLE critical appraisal tool. The in vivo anti- Leishmania potential of naphthoquinones was evaluated in visceral and cutaneous leishmaniasis using several measurement parameters. Analyzed compounds varied in structure, association with reference drugs, and encapsulation using a drug delivery system. The study design, including treatment protocol, differed between studies. The findings of the studies in this systematic review indicate the anti- Leishmania potential of naphthoquinones in vivo, with different treatment regimens directed against different Leishmania species. The employed drug delivery systems improve the results concerning selectivity, distribution, and required therapeutic dose. The immunomodulatory action was shown to be beneficial to the host, favoring an adequate immune response against infection by Leishmania parasites since it favored Th 1 responses. All studies presented a moderate to high risk of bias. These findings suggest that more studies are needed to assess the overall effectiveness and safety of these treatments. Graphical abstract
doi_str_mv 10.1007/s00436-022-07455-1
format Article
fullrecord <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_2631864501</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A699900221</galeid><sourcerecordid>A699900221</sourcerecordid><originalsourceid>FETCH-LOGICAL-c442t-6c9f26ad784d5277d2d42c8baf2145a52bd422c188df496fec8abc6c6d7c5ad33</originalsourceid><addsrcrecordid>eNp9Ustu1DAUjRCIDoUfYIEssekmg-3YeSxHFRSkkdiUteXYN42rxA62U9Q_4XO5YQoVCCEv7Ht9zrnPonjN6J5R2rxLlIqqLinnJW2ElCV7UuyYqHjJOimfFjva4ZsyVp0VL1K6pZQ1tRDPi7NKso62Tbsrvl-PQLTPrjyCS-OsvdNkCRnQpScSBtK7oE12d0BMmJewepuIhYgOS4YYZuL1MuYxfF2dDx4SqlmSR3ARdVJy_YQBlmVyRmcXfNqTA0n3KcOMtiER7hx82wJh6BlDprxaB-ll8WzQU4JXD_d58eXD--vLj-Xx89Wny8OxNELwXNamG3itbdMKK3nTWG4FN22vB86E1JL3aHPD2tYOoqsHMK3uTW1q2xipbVWdFxcn3SViCZCyml0yME3aQ1iT4nXF2lpIyhD69i_obVijx-wQJVopueDdI-pGT6CcH0KO2myi6lB3XUdxXpvW_h8oPBZmZ7CPg0P_HwR-IpiIXY0wqCViv-K9YlRt66BO66AQrX6ug9pIbx4yXvsZ7G_Kr_kjoDoBEn75G4iPJf1H9gflmcIP</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2648552429</pqid></control><display><type>article</type><title>The anti-Leishmania potential of bioactive compounds derived from naphthoquinones and their possible applications. A systematic review of animal studies</title><source>MEDLINE</source><source>SpringerLink Journals</source><creator>Ramos-Milaré, Áquila Carolina Fernandes Herculano ; Oyama, Jully ; Murase, Letícia Sayuri ; Souza, João Vítor Perez ; Guedes, Bárbara Silva ; Lera-Nonose, Daniele Stéfanie Sara Lopes ; Monich, Mariana Terron ; Brustolin, Aline Ávila ; Demarchi, Izabel Galhardo ; Teixeira, Jorge Juarez Vieira ; Lonardoni, Maria Valdrinez Campana</creator><creatorcontrib>Ramos-Milaré, Áquila Carolina Fernandes Herculano ; Oyama, Jully ; Murase, Letícia Sayuri ; Souza, João Vítor Perez ; Guedes, Bárbara Silva ; Lera-Nonose, Daniele Stéfanie Sara Lopes ; Monich, Mariana Terron ; Brustolin, Aline Ávila ; Demarchi, Izabel Galhardo ; Teixeira, Jorge Juarez Vieira ; Lonardoni, Maria Valdrinez Campana</creatorcontrib><description>Leishmaniasis affects millions of people worldwide, and available treatments have severe limitations. Natural and derivative products are significant sources of innovative therapeutic agents. Naphthoquinones are natural or synthetic chemical compounds with broad biological activity. This systematic review aimed to evaluate the potential anti- Leishmania activity of bioactive compounds derived from naphthoquinones in animal models. Conducted in accordance with PRISMA guidelines, two blocks of MeSH terms were assembled: group I, Leishmania OR Leishmaniasis; group II, Atovaquone OR Lapachol OR Beta lapachone OR Naphthoquinones. The search was performed on PubMed, Web of Science, SCOPUS, EMBASE, and Lilacs databases. Twenty-four articles were retrieved and submitted for quality assessment using the SYRCLE critical appraisal tool. The in vivo anti- Leishmania potential of naphthoquinones was evaluated in visceral and cutaneous leishmaniasis using several measurement parameters. Analyzed compounds varied in structure, association with reference drugs, and encapsulation using a drug delivery system. The study design, including treatment protocol, differed between studies. The findings of the studies in this systematic review indicate the anti- Leishmania potential of naphthoquinones in vivo, with different treatment regimens directed against different Leishmania species. The employed drug delivery systems improve the results concerning selectivity, distribution, and required therapeutic dose. The immunomodulatory action was shown to be beneficial to the host, favoring an adequate immune response against infection by Leishmania parasites since it favored Th 1 responses. All studies presented a moderate to high risk of bias. These findings suggest that more studies are needed to assess the overall effectiveness and safety of these treatments. Graphical abstract</description><identifier>ISSN: 0932-0113</identifier><identifier>EISSN: 1432-1955</identifier><identifier>DOI: 10.1007/s00436-022-07455-1</identifier><identifier>PMID: 35190878</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Animal models ; Animals ; Animals, Laboratory ; Antiprotozoal Agents - therapeutic use ; Atovaquone ; Bioactive compounds ; Biological activity ; Biomedical and Life Sciences ; Biomedicine ; Cutaneous leishmaniasis ; Drug delivery ; Drug delivery systems ; Drug development ; Drugs ; Health aspects ; Humans ; Immune response ; Immunology ; Immunomodulation ; Immunosuppressive agents ; Lapachone ; Leishmania ; Leishmaniasis ; Leishmaniasis, Cutaneous - drug therapy ; Lymphocytes T ; Medical innovations ; Medical Microbiology ; Microbiology ; Naphthoquinones - chemistry ; Naphthoquinones - pharmacology ; Parasitic diseases ; Pentamidine isethionate ; Quality control ; Reviews ; Systematic review ; Treatment and Prophylaxis - Review ; Vehicles</subject><ispartof>Parasitology research (1987), 2022-05, Vol.121 (5), p.1247-1280</ispartof><rights>The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2022</rights><rights>2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.</rights><rights>COPYRIGHT 2022 Springer</rights><rights>The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2022.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c442t-6c9f26ad784d5277d2d42c8baf2145a52bd422c188df496fec8abc6c6d7c5ad33</citedby><cites>FETCH-LOGICAL-c442t-6c9f26ad784d5277d2d42c8baf2145a52bd422c188df496fec8abc6c6d7c5ad33</cites><orcidid>0000-0001-9068-7958</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00436-022-07455-1$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00436-022-07455-1$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35190878$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ramos-Milaré, Áquila Carolina Fernandes Herculano</creatorcontrib><creatorcontrib>Oyama, Jully</creatorcontrib><creatorcontrib>Murase, Letícia Sayuri</creatorcontrib><creatorcontrib>Souza, João Vítor Perez</creatorcontrib><creatorcontrib>Guedes, Bárbara Silva</creatorcontrib><creatorcontrib>Lera-Nonose, Daniele Stéfanie Sara Lopes</creatorcontrib><creatorcontrib>Monich, Mariana Terron</creatorcontrib><creatorcontrib>Brustolin, Aline Ávila</creatorcontrib><creatorcontrib>Demarchi, Izabel Galhardo</creatorcontrib><creatorcontrib>Teixeira, Jorge Juarez Vieira</creatorcontrib><creatorcontrib>Lonardoni, Maria Valdrinez Campana</creatorcontrib><title>The anti-Leishmania potential of bioactive compounds derived from naphthoquinones and their possible applications. A systematic review of animal studies</title><title>Parasitology research (1987)</title><addtitle>Parasitol Res</addtitle><addtitle>Parasitol Res</addtitle><description>Leishmaniasis affects millions of people worldwide, and available treatments have severe limitations. Natural and derivative products are significant sources of innovative therapeutic agents. Naphthoquinones are natural or synthetic chemical compounds with broad biological activity. This systematic review aimed to evaluate the potential anti- Leishmania activity of bioactive compounds derived from naphthoquinones in animal models. Conducted in accordance with PRISMA guidelines, two blocks of MeSH terms were assembled: group I, Leishmania OR Leishmaniasis; group II, Atovaquone OR Lapachol OR Beta lapachone OR Naphthoquinones. The search was performed on PubMed, Web of Science, SCOPUS, EMBASE, and Lilacs databases. Twenty-four articles were retrieved and submitted for quality assessment using the SYRCLE critical appraisal tool. The in vivo anti- Leishmania potential of naphthoquinones was evaluated in visceral and cutaneous leishmaniasis using several measurement parameters. Analyzed compounds varied in structure, association with reference drugs, and encapsulation using a drug delivery system. The study design, including treatment protocol, differed between studies. The findings of the studies in this systematic review indicate the anti- Leishmania potential of naphthoquinones in vivo, with different treatment regimens directed against different Leishmania species. The employed drug delivery systems improve the results concerning selectivity, distribution, and required therapeutic dose. The immunomodulatory action was shown to be beneficial to the host, favoring an adequate immune response against infection by Leishmania parasites since it favored Th 1 responses. All studies presented a moderate to high risk of bias. These findings suggest that more studies are needed to assess the overall effectiveness and safety of these treatments. Graphical abstract</description><subject>Animal models</subject><subject>Animals</subject><subject>Animals, Laboratory</subject><subject>Antiprotozoal Agents - therapeutic use</subject><subject>Atovaquone</subject><subject>Bioactive compounds</subject><subject>Biological activity</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Cutaneous leishmaniasis</subject><subject>Drug delivery</subject><subject>Drug delivery systems</subject><subject>Drug development</subject><subject>Drugs</subject><subject>Health aspects</subject><subject>Humans</subject><subject>Immune response</subject><subject>Immunology</subject><subject>Immunomodulation</subject><subject>Immunosuppressive agents</subject><subject>Lapachone</subject><subject>Leishmania</subject><subject>Leishmaniasis</subject><subject>Leishmaniasis, Cutaneous - drug therapy</subject><subject>Lymphocytes T</subject><subject>Medical innovations</subject><subject>Medical Microbiology</subject><subject>Microbiology</subject><subject>Naphthoquinones - chemistry</subject><subject>Naphthoquinones - pharmacology</subject><subject>Parasitic diseases</subject><subject>Pentamidine isethionate</subject><subject>Quality control</subject><subject>Reviews</subject><subject>Systematic review</subject><subject>Treatment and Prophylaxis - Review</subject><subject>Vehicles</subject><issn>0932-0113</issn><issn>1432-1955</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9Ustu1DAUjRCIDoUfYIEssekmg-3YeSxHFRSkkdiUteXYN42rxA62U9Q_4XO5YQoVCCEv7Ht9zrnPonjN6J5R2rxLlIqqLinnJW2ElCV7UuyYqHjJOimfFjva4ZsyVp0VL1K6pZQ1tRDPi7NKso62Tbsrvl-PQLTPrjyCS-OsvdNkCRnQpScSBtK7oE12d0BMmJewepuIhYgOS4YYZuL1MuYxfF2dDx4SqlmSR3ARdVJy_YQBlmVyRmcXfNqTA0n3KcOMtiER7hx82wJh6BlDprxaB-ll8WzQU4JXD_d58eXD--vLj-Xx89Wny8OxNELwXNamG3itbdMKK3nTWG4FN22vB86E1JL3aHPD2tYOoqsHMK3uTW1q2xipbVWdFxcn3SViCZCyml0yME3aQ1iT4nXF2lpIyhD69i_obVijx-wQJVopueDdI-pGT6CcH0KO2myi6lB3XUdxXpvW_h8oPBZmZ7CPg0P_HwR-IpiIXY0wqCViv-K9YlRt66BO66AQrX6ug9pIbx4yXvsZ7G_Kr_kjoDoBEn75G4iPJf1H9gflmcIP</recordid><startdate>20220501</startdate><enddate>20220501</enddate><creator>Ramos-Milaré, Áquila Carolina Fernandes Herculano</creator><creator>Oyama, Jully</creator><creator>Murase, Letícia Sayuri</creator><creator>Souza, João Vítor Perez</creator><creator>Guedes, Bárbara Silva</creator><creator>Lera-Nonose, Daniele Stéfanie Sara Lopes</creator><creator>Monich, Mariana Terron</creator><creator>Brustolin, Aline Ávila</creator><creator>Demarchi, Izabel Galhardo</creator><creator>Teixeira, Jorge Juarez Vieira</creator><creator>Lonardoni, Maria Valdrinez Campana</creator><general>Springer Berlin Heidelberg</general><general>Springer</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-9068-7958</orcidid></search><sort><creationdate>20220501</creationdate><title>The anti-Leishmania potential of bioactive compounds derived from naphthoquinones and their possible applications. A systematic review of animal studies</title><author>Ramos-Milaré, Áquila Carolina Fernandes Herculano ; Oyama, Jully ; Murase, Letícia Sayuri ; Souza, João Vítor Perez ; Guedes, Bárbara Silva ; Lera-Nonose, Daniele Stéfanie Sara Lopes ; Monich, Mariana Terron ; Brustolin, Aline Ávila ; Demarchi, Izabel Galhardo ; Teixeira, Jorge Juarez Vieira ; Lonardoni, Maria Valdrinez Campana</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c442t-6c9f26ad784d5277d2d42c8baf2145a52bd422c188df496fec8abc6c6d7c5ad33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Animal models</topic><topic>Animals</topic><topic>Animals, Laboratory</topic><topic>Antiprotozoal Agents - therapeutic use</topic><topic>Atovaquone</topic><topic>Bioactive compounds</topic><topic>Biological activity</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Cutaneous leishmaniasis</topic><topic>Drug delivery</topic><topic>Drug delivery systems</topic><topic>Drug development</topic><topic>Drugs</topic><topic>Health aspects</topic><topic>Humans</topic><topic>Immune response</topic><topic>Immunology</topic><topic>Immunomodulation</topic><topic>Immunosuppressive agents</topic><topic>Lapachone</topic><topic>Leishmania</topic><topic>Leishmaniasis</topic><topic>Leishmaniasis, Cutaneous - drug therapy</topic><topic>Lymphocytes T</topic><topic>Medical innovations</topic><topic>Medical Microbiology</topic><topic>Microbiology</topic><topic>Naphthoquinones - chemistry</topic><topic>Naphthoquinones - pharmacology</topic><topic>Parasitic diseases</topic><topic>Pentamidine isethionate</topic><topic>Quality control</topic><topic>Reviews</topic><topic>Systematic review</topic><topic>Treatment and Prophylaxis - Review</topic><topic>Vehicles</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ramos-Milaré, Áquila Carolina Fernandes Herculano</creatorcontrib><creatorcontrib>Oyama, Jully</creatorcontrib><creatorcontrib>Murase, Letícia Sayuri</creatorcontrib><creatorcontrib>Souza, João Vítor Perez</creatorcontrib><creatorcontrib>Guedes, Bárbara Silva</creatorcontrib><creatorcontrib>Lera-Nonose, Daniele Stéfanie Sara Lopes</creatorcontrib><creatorcontrib>Monich, Mariana Terron</creatorcontrib><creatorcontrib>Brustolin, Aline Ávila</creatorcontrib><creatorcontrib>Demarchi, Izabel Galhardo</creatorcontrib><creatorcontrib>Teixeira, Jorge Juarez Vieira</creatorcontrib><creatorcontrib>Lonardoni, Maria Valdrinez Campana</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Parasitology research (1987)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ramos-Milaré, Áquila Carolina Fernandes Herculano</au><au>Oyama, Jully</au><au>Murase, Letícia Sayuri</au><au>Souza, João Vítor Perez</au><au>Guedes, Bárbara Silva</au><au>Lera-Nonose, Daniele Stéfanie Sara Lopes</au><au>Monich, Mariana Terron</au><au>Brustolin, Aline Ávila</au><au>Demarchi, Izabel Galhardo</au><au>Teixeira, Jorge Juarez Vieira</au><au>Lonardoni, Maria Valdrinez Campana</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The anti-Leishmania potential of bioactive compounds derived from naphthoquinones and their possible applications. A systematic review of animal studies</atitle><jtitle>Parasitology research (1987)</jtitle><stitle>Parasitol Res</stitle><addtitle>Parasitol Res</addtitle><date>2022-05-01</date><risdate>2022</risdate><volume>121</volume><issue>5</issue><spage>1247</spage><epage>1280</epage><pages>1247-1280</pages><issn>0932-0113</issn><eissn>1432-1955</eissn><abstract>Leishmaniasis affects millions of people worldwide, and available treatments have severe limitations. Natural and derivative products are significant sources of innovative therapeutic agents. Naphthoquinones are natural or synthetic chemical compounds with broad biological activity. This systematic review aimed to evaluate the potential anti- Leishmania activity of bioactive compounds derived from naphthoquinones in animal models. Conducted in accordance with PRISMA guidelines, two blocks of MeSH terms were assembled: group I, Leishmania OR Leishmaniasis; group II, Atovaquone OR Lapachol OR Beta lapachone OR Naphthoquinones. The search was performed on PubMed, Web of Science, SCOPUS, EMBASE, and Lilacs databases. Twenty-four articles were retrieved and submitted for quality assessment using the SYRCLE critical appraisal tool. The in vivo anti- Leishmania potential of naphthoquinones was evaluated in visceral and cutaneous leishmaniasis using several measurement parameters. Analyzed compounds varied in structure, association with reference drugs, and encapsulation using a drug delivery system. The study design, including treatment protocol, differed between studies. The findings of the studies in this systematic review indicate the anti- Leishmania potential of naphthoquinones in vivo, with different treatment regimens directed against different Leishmania species. The employed drug delivery systems improve the results concerning selectivity, distribution, and required therapeutic dose. The immunomodulatory action was shown to be beneficial to the host, favoring an adequate immune response against infection by Leishmania parasites since it favored Th 1 responses. All studies presented a moderate to high risk of bias. These findings suggest that more studies are needed to assess the overall effectiveness and safety of these treatments. Graphical abstract</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><pmid>35190878</pmid><doi>10.1007/s00436-022-07455-1</doi><tpages>34</tpages><orcidid>https://orcid.org/0000-0001-9068-7958</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0932-0113
ispartof Parasitology research (1987), 2022-05, Vol.121 (5), p.1247-1280
issn 0932-0113
1432-1955
language eng
recordid cdi_proquest_miscellaneous_2631864501
source MEDLINE; SpringerLink Journals
subjects Animal models
Animals
Animals, Laboratory
Antiprotozoal Agents - therapeutic use
Atovaquone
Bioactive compounds
Biological activity
Biomedical and Life Sciences
Biomedicine
Cutaneous leishmaniasis
Drug delivery
Drug delivery systems
Drug development
Drugs
Health aspects
Humans
Immune response
Immunology
Immunomodulation
Immunosuppressive agents
Lapachone
Leishmania
Leishmaniasis
Leishmaniasis, Cutaneous - drug therapy
Lymphocytes T
Medical innovations
Medical Microbiology
Microbiology
Naphthoquinones - chemistry
Naphthoquinones - pharmacology
Parasitic diseases
Pentamidine isethionate
Quality control
Reviews
Systematic review
Treatment and Prophylaxis - Review
Vehicles
title The anti-Leishmania potential of bioactive compounds derived from naphthoquinones and their possible applications. A systematic review of animal studies
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T11%3A59%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20anti-Leishmania%20potential%20of%20bioactive%20compounds%20derived%20from%20naphthoquinones%20and%20their%20possible%20applications.%20A%20systematic%20review%20of%20animal%20studies&rft.jtitle=Parasitology%20research%20(1987)&rft.au=Ramos-Milar%C3%A9,%20%C3%81quila%20Carolina%20Fernandes%20Herculano&rft.date=2022-05-01&rft.volume=121&rft.issue=5&rft.spage=1247&rft.epage=1280&rft.pages=1247-1280&rft.issn=0932-0113&rft.eissn=1432-1955&rft_id=info:doi/10.1007/s00436-022-07455-1&rft_dat=%3Cgale_proqu%3EA699900221%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2648552429&rft_id=info:pmid/35190878&rft_galeid=A699900221&rfr_iscdi=true